Rare Diseases
108 Employers in 177 locations
108 Employers in 177 locations
Employers working on Rare Diseases work in 79 other areas
Displaying 1 - 15 of 79 related areas- Cell and Gene Therapy (28)
- Therapeutics (24)
- Small Molecules (20)
- Biologics (13)
- COVID-19 (12)
- Antibodies (6)
- Artificial Intelligence (5)
- Biopharmaceuticals (5)
- Neurobiology (5)
- AAV (4)
- Cancer (4)
- Cancer Therapeutics (4)
- Drug Discovery (4)
- Metabolism (4)
Displaying 1 - 60 of 108 employers
Only three business areas are listed for each employer.Business Area(s)
Description
Developing genetic tests to detect rare diseases.
Business Area(s)
Description
The company has developed technology that for producing adeno-associated virus ...
Business Area(s)
Description
Abliva develops mitochondrial medicine. They have one project in clinical phase ...
Business Area(s)
Description
Adrestia Therapeutics is using genetic networks to reveal new ways to treat ...
Business Area(s)
Description
Agios works on cellular metabolism and precision medicine across three major ...
Business Area(s)
Description
Alexion Pharmaceuticals is part of Astra Zeneca and is developing treatments for ...
Business Area(s)
Description
Alnylam develops innovative RNAi-based medicines in four therapeutic areas ...
Business Area(s)
Description
Amicus Therapeutics is a global, biotech company focused on discovering ...
Business Area(s)
Description
Developing treatments for Epidermolysis Bullosa, a group of rare and genetic ...
Business Area(s)
Description
Gene Therapy for Friedrich's ataxia
Business Area(s)
Description
Applied Therapeutics is a clinical-stage biopharmaceutical company developing a ...
Business Area(s)
Description
The company is working to develop products that address rare endocrine diseases ...
Business Area(s)
Description
AskBio is a subsidiary of Bayer AG. The company develops cell and gene therapies ...
Business Area(s)
Description
Cerecor is building a global biopharmaceutical enterprise with a near-term ...
Business Area(s)
Description
Azafaros was founded in 2018 to address rare genetic metabolic disorders through ...
Business Area(s)
Description
Beacon Therapeutics is developing genetic therapies to treat patients with rare ...
Business Area(s)
Description
BioCryst develops drugs to treat rare diseases. Galidesivir (BCX4430), an anti ...
Business Area(s)
Description
Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage ...
Business Area(s)
Description
BioMarin focuses on developing therapeutics for patients who live with serious ...
Business Area(s)
Description
BioXcel is a biopharmaceutical company that uses artificial intelligence and big ...
Business Area(s)
Description
BOOST Pharma focuses on high-bone-forming, allogeneic cell therapies for rare ...
Business Area(s)
Description
Bridgebio is a collection of individuals focused on discovering and developing ...
Business Area(s)
Description
Caraway Therapeutics is pursuing approaches for the treatment of debilitating ...
Business Area(s)
Description
Castle Creek Biosciences, Inc., a clinical-stage cell and gene therapy company ...
Business Area(s)
Description
Castle Creek Pharma is a biopharmaceutical company with a focus on the treatment ...
Business Area(s)
Description
CENTOGENE develops tests for the genetic diagnostics for rare hereditary ...
Business Area(s)
Description
Chiesi Farmaceutici S.p.A. is an Italian family controlled global pharmaceutical ...
Business Area(s)
Description
Chromocell is focused on the discovery and development of therapeutics and ...
Business Area(s)
Description
Coave Therapeutics is a clinical stage biotechnology company focused on ...
Business Area(s)
Description
Code Bio is developing next-generation gene therapies for patients with rare and ...
Business Area(s)
Description
Collaborations Pharmaceuticals, Inc.® performs research and development on ...
Business Area(s)
Description
Constant is a clinical stage company developing Mas receptor agonists for ...
Business Area(s)
Description
CSL is a global biotechnology company with a dynamic portfolio of lifesaving ...
Business Area(s)
Description
CSL Behring is a biopharmaceutical company that manufactures plasma-derived and ...
Business Area(s)
Description
CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that ...
Business Area(s)
Description
Cyclerion was founded with the goal of unlocking the full therapeutic potential ...
Business Area(s)
Description
Egetis is a pharmaceutical company, focusing on projects in late-stage ...
Business Area(s)
Description
The company is investigating how the ZSCAN4 gene might be useful in cell ...
Business Area(s)
Description
Emalex Biosciences develops treatments for central nervous system movement ...
Business Area(s)
Description
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the ...
Business Area(s)
Description
EpiSignâ„¢ is a clinically validated test that analyzes genomic DNA methylation ...
Business Area(s)
Description
Founded in Lyon, France in 2004, ERYTECH is a clinical-stage biopharmaceutical ...
Business Area(s)
Description
Exegenesis Bio is a clinical-stage global cell and gene therapy company that ...
Business Area(s)
Description
Early-stage research on 505(b)(2) products
Business Area(s)
Description
GeneDx provides genomics testing with expertise in rare and ultra-rare genetic ...
Business Area(s)
Description
Grace Therapeutics is a late-stage biopharma company with drug candidates ...
Business Area(s)
Description
The company is working to develop lifesaving and life altering therapies for ...
Business Area(s)
Description
Harmony Biosciences, LLC, is a private biopharmaceutical company headquartered ...
Business Area(s)
Description
HBM Alpha Therapeutics. HBM Alpha Therapeutics is a company presently developing ...
Business Area(s)
Description
Developed an AI platform for rare disease drug discovery.
Business Area(s)
Description
Homology Medicines is working to use gene editing and gene therapy to bring new ...
Business Area(s)
Description
Developing a drug discovery platform for allosteric medicines.
Business Area(s)
Description
Engineers B cells through gene therapy to produce proteins that combat disease ...
Business Area(s)
Description
The mission of Infixion Bioscience is to develop treatments to eradicate NF1, a ...
Business Area(s)
Description
The company is working on an in vivo gene-editing therapy for the treatment of ...
Business Area(s)
Description
IntraBio Inc. is focused on the development and commercialization of drugs for ...